3 Questions to Ask When Developing IP Strategy for Your Tech Startup

Taking the time to plan an intellectual property (IP) strategy appropriate for your technology startup can yield a substantial return. It can help your business secure its competitive advantage, grow its market share, and increase its valuation. For most businesses, an effective IP strategy will prioritize the IP that protects their core assets: Trademarks protect… Continue reading 3 Questions to Ask When Developing IP Strategy for Your Tech Startup

Intellectual Property – IP: What’s In It For You?

Mr. Patrick Hofbauer from the Intellectual Property Office will be delivering the presentation Patrick has over 30 years of intellectual property (“IP”) law experience with clients ranging from individual entrepreneurs to multinational corporations. He has extensive experience in the filing and prosecution of mechanical, electro/mechanical and chemical patent applications, trademark applications, the preparation and negotiation… Continue reading Intellectual Property – IP: What’s In It For You?

Intellectual Property Landscape with Bereskin & Parr

Bereskin & Parr hosts an Intellectual Property Landscape Breakfast on September 30! Key Highlights: What to consider in obtaining strong patent, design and trademark protection How to maximize your chances of obtaining patent protection What to know about the “big three” Canadian IP statutes updates: Patent Act – implementing the Patent Law Treaty Trademarks Act… Continue reading Intellectual Property Landscape with Bereskin & Parr

Altitude Accelerator announces Startup Boot Camp

Media Release For Release Sep 18, 2015 Altitude Accelerator announces Startup Boot Camp Brampton, ON– Sept 18, 2015 – Paul Bertin, Altitude Accelerator Chair announced, “Startup Boot Camp”, a new initiative developed in partnership with Bereskin & Parr and Pallett Valo,” at the Convergence Event in Brampton. Bereskin & Parr and Pallett Valo have partnered with Altitude… Continue reading Altitude Accelerator announces Startup Boot Camp

Isolated Human Genes are No Longer Patentable in the United States

Monday, June 17, 2013 By: Serge Lapointe, Ph.D. | Montréal and Ingrid E. VanderElst | Toronto The United States Supreme Court has released its much anticipated decision in the case of Association for Molecular Pathology v. Myriad Genetics, Inc. In a decision that will have a significant impact on the biotechnology industry, the Supreme Court unanimously decided… Continue reading Isolated Human Genes are No Longer Patentable in the United States

Defensive Patent License: Is it the Answer for Innovators?

By: Shanza Anwaar For an inventor or technical innovator, more sleepless nights are spent over how to protect what could be your very own goldmine than any other issue. According to Politico, tech companies continue to “occupy top of the patent heap.” If giants like Apple and Samsung, Google and Microsoft, are engaged in long… Continue reading Defensive Patent License: Is it the Answer for Innovators?

Patent filing is back on the rise – WIPO publishes two valuable reports

By James Taylor Two reports published by the World Intellectual Property Office (WIPO) demonstrate that patent filing is back on the rise and is of increasing value to stakeholders. This is interesting news for biotech startups and other companies who’s value is often determined by their cutting edge intellectual property. Each year, WIPO publishes an… Continue reading Patent filing is back on the rise – WIPO publishes two valuable reports

U.S. Patent Reform: Act Incents Smaller Firms to Innovate

By Jasmeet Duggal On September 16th, the America Invents Act was signed into law in the United States. Under the Act, the patent filing system has changed from “first-to-invent” to “first-to-file.”  This allows the first inventor to file for a patent to receive the rights to the invention. Once implemented, it is intended that the… Continue reading U.S. Patent Reform: Act Incents Smaller Firms to Innovate

IP Constituencies: Indian Industry Lobbies to Keep IP Out of Free Trade Agreement with EU

By Jeremy Grushcow An article in the Hindu Business Line says the Indian Drug Manufacturers’ Association is lobbying heavily to keep data protection and other innovator-friendly IP provisions out of the free trade agreement being negotiated between India and the EU. But, with Glenmark and Jubilant on the rise, and with even Biocon carrying the R&D… Continue reading IP Constituencies: Indian Industry Lobbies to Keep IP Out of Free Trade Agreement with EU